Paul R. Thomas
National Academy of Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paul R. Thomas.
Archive | 1995
Treat Obesity; Paul R. Thomas
If you get the printed book in on-line book store, you may also find the same problem. So, you must move store to store and search for the available there. But, it will not happen here. The book that we will offer right here is the soft file concept. This is what make you can easily find and get this weighing the options criteria for evaluating weight management programs by reading this site. We offer you the best product, always and always.
Pediatric Research | 2013
Regan L Bailey; Jaime J. Gahche; Paul R. Thomas; Johanna T. Dwyer
Background:Dietary supplements are used by one-third of children. We examined motivations for supplement use in children, the types of products used by motivations, and the role of physicians and health care practitioners in guiding choices about supplements.Methods:We examined motivations for dietary supplement use reported for children (from birth to 19 y of age; n = 8,245) using the National Health and Nutrition Examination Survey 2007–2010.Results:Dietary supplements were used by 31% of children; many different reasons were given as follows: to “improve overall health” (41%), to “maintain health” (37%), for “supplementing the diet” (23%), to “prevent health problems” (20%), and to “boost immunity” (14%). Most children (~90%) who use dietary supplements use a multivitamin–mineral or multivitamin product. Supplement users tend to be non-Hispanic white, have higher family incomes, report more physical activity, and have health insurance. Only a small group of supplements used by children (15%) were based on the recommendation of a physician or other health care provider.Conclusion:Most supplements used by children are not under the recommendation of a health care provider. The most common reasons for use of supplements in children are for health promotion, yet little scientific data support this notion in nutrient-replete children.
Journal of Nutrition | 2015
Regan L Bailey; Tala H. I. Fakhouri; Yikyung Park; Johanna T. Dwyer; Paul R. Thomas; Jaime J. Gahche; Paige E. Miller; Kevin W. Dodd; Christopher T. Sempos; David M. Murray
BACKGROUND Multivitamin-mineral (MVM) products are the most commonly used supplements in the United States, followed by multivitamin (MV) products. Two randomized clinical trials (RCTs) did not show an effect of MVMs or MVs on cardiovascular disease (CVD) mortality; however, no clinical trial data are available for women with MVM supplement use and CVD mortality. OBJECTIVE The objective of this research was to examine the association between MVM and MV use and CVD-specific mortality among US adults without CVD. METHODS A nationally representative sample of adults from the restricted data NHANES III (1988-1994; n = 8678; age ≥40 y) were matched with mortality data reported by the National Death Index through 2011 to examine associations between MVM and MV use and CVD mortality by using Cox proportional hazards models, adjusting for multiple potential confounders. RESULTS We observed no significant association between CVD mortality and users of MVMs or MVs compared with nonusers; however, when users were classified by the reported length of time products were used, a significant association was found with MVM use of >3 y compared with nonusers (HR: 0.65; 95% CI: 0.49, 0.85). This finding was largely driven by the significant association among women (HR: 0.56; 95% CI: 0.37, 0.85) but not men (HR: 0.79; 95% CI: 0.44, 1.42). No significant association was observed for MV products and CVD mortality in fully adjusted models. CONCLUSIONS In this nationally representative data set with detailed information on supplement use and CVD mortality data ∼20 y later, we found an association between MVM use of >3 y and reduced CVD mortality risk for women when models controlled for age, race, education, body mass index, alcohol, aspirin use, serum lipids, blood pressure, and blood glucose/glycated hemoglobin. Our results are consistent with the 1 available RCT in men, indicating no relation with MVM use and CVD mortality.
JAMA Internal Medicine | 2013
Regan L. Bailey; Jaime J. Gahche; Paige E. Miller; Paul R. Thomas; Johanna T. Dwyer
Archive | 1992
Catherine E. Woteki; Paul R. Thomas
Journal of Nutrition Education | 1991
Paul R. Thomas
Archive | 1995
Treat Obesity; Paul R. Thomas
Archive | 1994
Paul R. Thomas; Robert O. Earl
Archive | 1991
Paul R. Thomas
Archive | 1992
Catherine E. Woteki; Paul R. Thomas